Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-21 | 190686 |
| TEVA-ZOPICLONE | 5MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195195 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195506 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Actual shortage | 2023-06-19 | 2023-11-03 | 195652 |
| TEVA-AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Avoided shortage | 2023-06-20 | 2023-07-05 | 195891 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Actual shortage | 2023-07-11 | 2024-05-03 | 198303 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2023-07-11 | 2023-07-21 | 198319 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Actual shortage | 2023-08-17 | 2024-05-09 | 202252 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2023-12-14 | 2024-02-15 | 213365 |
| TEVA-TEMOZOLOMIDE | 5MG | CAPSULE | Actual shortage | 2024-02-08 | 2024-02-08 | 218986 |
| TEVA-DONEPEZIL | 5MG | TABLET | Actual shortage | 2024-03-21 | 2024-05-03 | 222941 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223844 |
| TEVA-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223859 |
| TEVA-EVEROLIMUS | 5MG | TABLET | Actual shortage | 2024-05-09 | 2024-05-09 | 227509 |
| TEVA-AMPHETAMINE XR | 5MG 5MG 5MG 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60075 |
| TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Actual shortage | 2019-07-02 | 2021-01-14 | 88222 |
| TEVA-PROCTOSONE | 5MG 5MG 10MG 10MG | OINTMENT | Actual shortage | 2019-07-02 | 2021-01-14 | 88225 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92229 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2020-03-06 | 2020-03-26 | 108027 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Actual shortage | 2021-08-27 | 2022-08-18 | 144701 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
| TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |